Stan Smith - Apr 25, 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Stock symbol
MAIA
Transactions as of
Apr 25, 2024
Transactions value $
$632,741
Form type
4
Date filed
4/26/2024, 05:30 PM
Previous filing
Apr 2, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $299K +147K +17.2% $2.03 1.01M Apr 25, 2024 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Warrants Purchase $333K +147K $2.26 147K Apr 25, 2024 Common Stock 147K $2.26 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
F3 The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.
F4 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.